Health News

(MedPage Today) — Makers of a supplement marketed as a male sexual enhancement product issued a voluntary recall of the product after an FDA analysis found undeclared traces of sulfoaildenafil, an analog to the erectile dysfunction drug sildenafil.

Read more

Filed under: General Health News
Tags: Drug, General Health News, male

Related posts

• Study first to pinpoint why analgesic drugs may be less potent in females than in males (0)
  (Georgia State University) Investigators at Georgia State University's Neuroscience Institute and Center for Behavioral Neuroscience are the first to identify the most likely reason analgesic drug treatment is usually less potent in females than males. This discovery is a major step toward finding more effective treatments for females suffering from persistent pain. Read more [tags] General Health [...]
  
  
• Younger Patients More Often Unable to Afford Prescriptions (0)
  WASHINGTON (MedPage Today) -- The cost of prescription drugs is proving a barrier to many Americans well before they reach Medicare age, even as young as childhood, according to a survey released here. Read more [tags] General Health News [/tags]
  
  
• Young adults need to make more time for healthy meals (0)
  (Elsevier Health Sciences) In a study published in the January 2009 issue of the Journal of the American Dietetic Association, researchers observed that while young adults enjoy and value time spent eating with others, 35 percent of males and 42 percent of females reported lacking time to sit down and eat a meal. They further [...]
  
  
• XDR-TB: Deadlier and more mysterious than ever (0)
  (American Thoracic Society) New research has found that extensively drug-resistant tuberculosis is increasingly common and more deadly than previously known. Extensively drug-resistant tuberculosis is a growing public health threat that is only just beginning to be understood by medical and public health officials. Read more [tags] General Health News [/tags]
  
  
• XDR-TB declining in the U.S. (0)
  A new report suggests that the number of cases of extensively drug-resistant tuberculosis (XDR-TB) in the U.S. has declined in the past fifteen years, but new cases continue to be reported, according to the study published in the November 12 issue of JAMA. Read more [tags] General Health News [/tags]